Global Diagnostic Catheter Market

1 INTRODUCTION OF GLOBAL DIAGNOSTIC CATHETER MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL DIAGNOSTIC CATHETER MARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL DIAGNOSTIC CATHETER MARKET, BY APPLICATION AREA:
5.1 Cardiology
5.2 Urology
5.3 Gastroenterology
5.4 Neurology
5.5 Other Application Areas

6 GLOBAL DIAGNOSTIC CATHETER MARKET, BY END USER:
6.1 Hospitals
6.2 Diagnostic & Imaging Centers

7 GLOBAL DIAGNOSTIC CATHETER MARKET, BY TYPE:
7.1 Diagnostic Imaging Catheters
7.1.1 Angiography Catheters
7.1.2 Electrophysiology Catheters
7.1.2.1 Conventional Electrophysiology Catheters
7.1.2.2 Advanced Electrophysiology Catheters
7.1.3 Ultrasound Catheters
7.1.4 Oct Catheters
7.1.5 Other Diagnostic Imaging Catheters
7.2 Non-Imaging Diagnostic Catheter
7.2.1 Pressure and Hemodymanic Monitoring Catheters
7.2.2 Temperature Monitoring Catheters
7.2.3 Other Non-Imaging Diagnostic Catheter

8 GLOBAL DIAGNOSTIC CATHETER MARKET, BY GEOGRAPHY
8.1 Overview
8.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
8.5.1 Brazil
8.5.2 Argentina
8.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 - 2025

9 GLOBAL DIAGNOSTIC CATHETER MARKETCOMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Share
9.3 Vendor Landscape
9.4 Key Development Strategies

10 COMPANY PROFILES
10.1 Boston Scientific Corporation
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments

10.2 St. Jude Medical, Inc.
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments

10.3 Johnson & Johnson
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments

10.4 Medtronic PLC
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments

10.5 Koninklijke Philips N.V.
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments

10.6 B. Braun Melsungen AG
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments

10.7 C. R. Bard, Inc.
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments

10.8 Cardinal Health, Inc.
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments

10.9 Terumo Corporation
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Developments

10.10 Edwards Lifesciences Corporation
10.10.1 Overview
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Developments

11 Appendix
11.1 Related Reports